Tenon Medical Inc. (TNON)
Tenon Medical Statistics
Share Statistics
Tenon Medical has 3.14M shares outstanding. The number of shares has increased by 63.98% in one year.
Shares Outstanding | 3.14M |
Shares Change (YoY) | 63.98% |
Shares Change (QoQ) | 97.67% |
Owned by Institutions (%) | 39.39% |
Shares Floating | 3.14M |
Failed to Deliver (FTD) Shares | 961 |
FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 206.66K, so 6.59% of the outstanding shares have been sold short.
Short Interest | 206.66K |
Short % of Shares Out | 6.59% |
Short % of Float | 6.59% |
Short Ratio (days to cover) | 0.11 |
Valuation Ratios
The PE ratio is -0.17 and the forward PE ratio is -0.15. Tenon Medical's PEG ratio is 0.
PE Ratio | -0.17 |
Forward PE | -0.15 |
PS Ratio | 0.7 |
Forward PS | 0.5 |
PB Ratio | 0.38 |
P/FCF Ratio | -0.23 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Tenon Medical.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.39, with a Debt / Equity ratio of 0.07.
Current Ratio | 4.39 |
Quick Ratio | 4.07 |
Debt / Equity | 0.07 |
Debt / EBITDA | -0.03 |
Debt / FCF | -0.04 |
Interest Coverage | -404.88 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $121.37K |
Profits Per Employee | $-506.41K |
Employee Count | 27 |
Asset Turnover | 0.33 |
Inventory Turnover | 2.58 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -81.76% in the last 52 weeks. The beta is 1.9, so Tenon Medical's price volatility has been higher than the market average.
Beta | 1.9 |
52-Week Price Change | -81.76% |
50-Day Moving Average | 1.52 |
200-Day Moving Average | 3.2 |
Relative Strength Index (RSI) | 46.19 |
Average Volume (20 Days) | 7.27M |
Income Statement
In the last 12 months, Tenon Medical had revenue of 3.28M and earned -13.67M in profits. Earnings per share was -11.26.
Revenue | 3.28M |
Gross Profit | 1.71M |
Operating Income | -13.77M |
Net Income | -13.67M |
EBITDA | -13.77M |
EBIT | -13.64M |
Earnings Per Share (EPS) | -11.26 |
Balance Sheet
The company has 6.54M in cash and 428K in debt, giving a net cash position of 6.11M.
Cash & Cash Equivalents | 6.54M |
Total Debt | 428K |
Net Cash | 6.11M |
Retained Earnings | -68.75M |
Total Assets | 13.04M |
Working Capital | 8.01M |
Cash Flow
In the last 12 months, operating cash flow was -9.88M and capital expenditures -186K, giving a free cash flow of -10.06M.
Operating Cash Flow | -9.88M |
Capital Expenditures | -186K |
Free Cash Flow | -10.06M |
FCF Per Share | -8.29 |
Margins
Gross margin is 52.21%, with operating and profit margins of -420.08% and -417.24%.
Gross Margin | 52.21% |
Operating Margin | -420.08% |
Pretax Margin | -417.24% |
Profit Margin | -417.24% |
EBITDA Margin | -420.08% |
EBIT Margin | -420.08% |
FCF Margin | -307.11% |
Dividends & Yields
TNON does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for TNON is $16, which is 1103% higher than the current price. The consensus rating is "Buy".
Price Target | $16 |
Price Target Difference | 1103% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Stock Splits
The last stock split was on Sep 6, 2024. It was a backward split with a ratio of 1:8.
Last Split Date | Sep 6, 2024 |
Split Type | backward |
Split Ratio | 1:8 |
Scores
Altman Z-Score | -8.22 |
Piotroski F-Score | 3 |